Status:
COMPLETED
Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
Lead Sponsor:
Vanderbilt University
Conditions:
Glaucoma
Macular Pucker
Eligibility:
All Genders
18+ years
Brief Summary
Since the introduction of vitrectomy in 1971, this procedure has become the third most frequently performed ophthalmic surgery. Approximately 225,000 vitrectomies are performed annually in the United ...
Eligibility Criteria
Inclusion
- Able to consent and comply for the duration of the study and imaging studies
- Media clarity sufficient for imaging studies
- No previous treatment or surgery that might confound study results in the study or fellow eye
- Pars plana vitrectomy (PPV) indicated for epiretinal membrane (ERM), macular hole (MH), vitreo-macular traction (VMT), and vitreous hemorrhage (VH)
Exclusion
- Unable to consent and/or comply for the duration of the study and imaging studies
- History of the following conditions: Glaucoma or associated conditions, visual field defects, uveitis, age-related macular degeneration (ARMD), prior PPV for retinal detachment, retained lens or dislocated intraocular lens
- Contralateral eye status post PPV or with advanced eye disease serious enough to warrant future PPV - Contralateral eye with condition that may result in choroidal neovascular membrane
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2017
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01162356
Start Date
July 1 2010
End Date
January 24 2017
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Eye Institute
Nashville, Tennessee, United States, 37203